Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.
Saved in:
| Title: | Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. |
|---|---|
| Authors: | Rugo HS; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. Electronic address: hrugo@medicine.ucsf.edu., Pritchard KI; Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada., Gnant M; Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Noguchi S; Department of Breast and Endocrine Surgery, Osaka University, Osaka, Japan., Piccart M; Institut Jules Bordet, Brussels, Belgium., Hortobagyi G; The University of Texas MD Anderson Cancer Center, Houston., Baselga J; Memorial Sloan-Kettering Cancer Center, New York., Perez A; Memorial Cancer Institute, Hollywood, USA., Geberth M; Praxisklinic am Rosengarten Mannheim, Schwerpunktpraxis für Gynaekologische Onkologie, Mannheim, Germany., Csoszi T; Department of Medical Oncology, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Hungary., Chouinard E; Cambridge Memorial Hospital, Cambridge, Canada., Srimuninnimit V; Siriraj Hospital, Mahidol University, Bangkok., Puttawibul P; Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand., Eakle J; Florida Cancer Specialists, Ft Myers., Feng W; Novartis Pharmaceuticals Corporation, East Hanover, USA., Bauly H; Novartis Pharma AG, Basel, Switzerland., El-Hashimy M; Novartis Pharmaceuticals Corporation, East Hanover, USA., Taran T; Novartis Pharmaceuticals Corporation, East Hanover, USA., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, USA. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Apr; Vol. 25 (4), pp. 808-815. Date of Electronic Publication: 2014 Mar 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
